Clinical Trial Update: A Randomized Controlled Trial of InterVapor® in France - The TARGET Trial [NA]

View source ↗

Summary

A randomized controlled trial of InterVapor for emphysema in France (TARGET) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emphysema

Drugs mentioned

• InterVapor

Snippet

Sponsor: Uptake Medical Technology, Inc. | Conditions: Emphysema | NA | Status: TERMINATED